| Nivolumab (USAN/INN); Nivolumab (genetical recombination) (JAN) <JP/US> |
| Pembrolizumab (USAN); Pembrolizumab (genetical recombination) (JAN) <JP/US> |
| Durvalumab (USAN/INN); Durvalumab (genetical recombination) (JAN) <JP/US> |
| Avelumab (USAN/INN); Avelumab (genetical recombination) (JAN) <JP/US> |
| Atezolizumab (USAN/INN); Atezolizumab (genetical recombination) (JAN) <JP/US> |
| Cemiplimab (USAN); Cemiplimab (genetical recombination) (JAN) <JP/US> |
| Dostarlimab (USAN); Dostarlimab (genetical recombination) (JAN) <US> |
| Tislelizumab (USAN/INN); Tislelizumab (genetical recombination) (JAN) <US> |
| Retifanlimab (USAN); Retifanlimab (genetical recombination) (JAN) <US> |
| Sugemalimab (INN) |
| Serplulimab (INN) |
| Toripalimab (USAN/INN) <US> |
| Ipilimumab (USAN/INN); Ipilimumab (genetical recombination) (JAN) <JP/US> |
| Tremelimumab (USAN/INN); Tremelimumab (genetical recombination) (JAN) <JP/US> |
| Nivolumab and relatlimab <US> |
| Pidilizumab (USAN/INN) |
| Relatlimab (USAN) |
| Tiragolumab (USAN/INN); Tiragolumab (genetical recombination) (JAN) |
| Cetrelimab (USAN/INN); Cetrelimab (genetical recombination) (JAN) |
| Lodapolimab (USAN) |
| Etigilimab (USAN/INN) |
| Spartalizumab (USAN/INN); Spartalizumab (genetical recombination) (JAN) |
| Budigalimab (USAN/INN) |
| Inbakicept (USAN/INN) |
| Vibostolimab (USAN/INN); Vibostolimab (genetical recombination) (JAN) |
| Balstilimab (USAN/INN) |
| Zalifrelimab (USAN/INN) |
| Bintrafusp alfa (USAN/INN); Bintrafusp alfa (genetical recombination) (JAN) |
| Cosibelimab (USAN/INN) |
| Pacmilimab (USAN/INN) |
| Zimberelimab (USAN) |
| Sintilimab (USAN/INN) |
| Pimivalimab (USAN) |
| Ieramilimab (USAN/INN) |
| Vudalimab (USAN) |
| Cadonilimab (USAN/INN) |
| Izuralimab (USAN) |
| Penpulimab (USAN) |
| Quavonlimab (USAN/INN) |
| Ociperlimab (USAN/INN) |
| Bavunalimab (USAN/INN) |
| Zeluvalimab (USAN/INN) |
| Volrustomig (USAN) |
| Belrestotug (USAN) |
| Danburstotug (USAN) |
| Domvanalimab (USAN/INN) |
| Botensilimab (USAN/INN) |
| Favezelimab (USAN/INN); Favezelimab (genetical recombination) (JAN) |
| Tuparstobart (USAN/INN) |
| Enristomig (USAN) |
| Rilvegostomig (USAN/INN) |
| Sasanlimab (USAN/INN); Sasanlimab (genetical recombination) (JAN) |
| Zimistobart |
| Tobemstomig (USAN/INN) |
| Dargistotug (USAN/INN) |
| Vilastobart (USAN/INN) |